1. Home
  2. ORIC vs BAND Comparison

ORIC vs BAND Comparison

Compare ORIC & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • BAND
  • Stock Information
  • Founded
  • ORIC 2014
  • BAND 2000
  • Country
  • ORIC United States
  • BAND United States
  • Employees
  • ORIC N/A
  • BAND N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • ORIC Health Care
  • BAND Technology
  • Exchange
  • ORIC Nasdaq
  • BAND Nasdaq
  • Market Cap
  • ORIC 362.9M
  • BAND 358.3M
  • IPO Year
  • ORIC 2020
  • BAND 2017
  • Fundamental
  • Price
  • ORIC $10.65
  • BAND $16.11
  • Analyst Decision
  • ORIC Strong Buy
  • BAND Buy
  • Analyst Count
  • ORIC 8
  • BAND 6
  • Target Price
  • ORIC $18.83
  • BAND $20.80
  • AVG Volume (30 Days)
  • ORIC 1.2M
  • BAND 263.1K
  • Earning Date
  • ORIC 08-11-2025
  • BAND 07-31-2025
  • Dividend Yield
  • ORIC N/A
  • BAND N/A
  • EPS Growth
  • ORIC N/A
  • BAND N/A
  • EPS
  • ORIC N/A
  • BAND N/A
  • Revenue
  • ORIC N/A
  • BAND $751,695,000.00
  • Revenue This Year
  • ORIC N/A
  • BAND $2.41
  • Revenue Next Year
  • ORIC N/A
  • BAND $13.51
  • P/E Ratio
  • ORIC N/A
  • BAND N/A
  • Revenue Growth
  • ORIC N/A
  • BAND 18.51
  • 52 Week Low
  • ORIC $3.90
  • BAND $11.33
  • 52 Week High
  • ORIC $14.67
  • BAND $23.90
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 70.08
  • BAND 68.55
  • Support Level
  • ORIC $9.80
  • BAND $13.69
  • Resistance Level
  • ORIC $10.99
  • BAND $16.35
  • Average True Range (ATR)
  • ORIC 0.66
  • BAND 0.49
  • MACD
  • ORIC -0.05
  • BAND 0.17
  • Stochastic Oscillator
  • ORIC 76.92
  • BAND 91.11

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: